Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514305 · ClinicalTrials.gov registry record
Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System
A clinical trial, sponsored by DexCom.
- Completed
- Registry status
- 21
- Enrollment target
NCT01514305 is a clinical trial that has completed, run by DexCom. The registered enrollment target is 21 participants.
The verdict
NCT01514305 has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness and safety of the Dexcom G4 System when used as an adjuvant to blood glucose testing. Device performance will be primarily evaluated in terms of the proportion of glucose values within a pre-specified range compared to reference values. Safety data of the G4 System will also be collected vis-a-vis adverse event reporting characterized by the incidence and severity of Serious Adverse Device Events, and Adverse Device Events experienced by study participants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-11 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01514305
The ClinicalTrials.gov registry entry for NCT01514305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01514305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01514305 about?
NCT01514305 is a clinical study titled "Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System". The purpose of this study is to evaluate the effectiveness and safety of the Dexcom G4 System when used as an adjuvant to blood glucose testing. Device performance will be primarily evaluated in terms of the proportion of glucose values within a pre-specified range compared to reference values. Sa...
What is the current status of trial NCT01514305?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2011-11. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01514305?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.